← All organizations
Highest phase reached
Phase 3
First clinical trial
Oct 1, 2015Last known activity
Jun 23, 2025
Timeline
2010s
- Jun 1, 2012
Viking Therapeutics, Inc.— Founded
Drugs by trial phase (4 distinct, 9 trials)
Indications
Recent trials (13)
- NCT07104500Lead sponsorPhase 3Jun 23, 2025
- NCT07104383Lead sponsorPhase 3Jun 23, 2025
- NCT06828055Lead sponsorPhase 2Dec 18, 2024
- NCT06068946Lead sponsorPhase 2Aug 31, 2023
- NCT05203237Lead sponsorPhase 1Dec 14, 2021
- NCT05203237Study directorPhase 1Dec 14, 2021
- NCT04973657Lead sponsorPhase 1Jun 22, 2021
- NCT04173065Lead sponsorPhase 2Nov 15, 2019
- NCT04173065Study directorPhase 2Nov 15, 2019
- NCT02927184Study directorPhase 2Aug 1, 2016
- NCT02927184Lead sponsorPhase 2Aug 1, 2016
- NCT02578095Lead sponsorPhase 2Oct 1, 2015
- NCT02578095Study directorPhase 2Oct 1, 2015
Details
- Founded
- San Diego, CA, US Jun 1, 2012
- Last known activity
- Jun 23, 2025